期刊
NATURE CELL BIOLOGY
卷 20, 期 10, 页码 1193-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41556-018-0179-z
关键词
-
类别
资金
- Academic Medical Center (Amsterdam)
- New York Stem Cell Foundation
- Cancer Research UK
- KWF [UVA2011-4969, UVA2014-7245, 10529]
- Maurits en Anna de Kock Stichting [2015-2]
- Worldwide Cancer Research [14-1164]
- Maag Lever Darm Stichting [MLDS-CDG 14-03]
- European Research Council [ERG-StG 638193]
- ZonMw [Vidi 016.156.308]
Solid malignancies have been speculated to depend on cancer stem cells (CSCs) for expansion and relapse after therapy. Here we report on quantitative analyses of lineage tracing data from primary colon cancer xenograft tissue to assess CSC functionality in a human solid malignancy. The temporally obtained clone size distribution data support a model in which stem cell function in established cancers is not intrinsically, but is entirely spatiotemporally orchestrated. Functional stem cells that drive tumour expansion predominantly reside at the tumour edge, close to cancer-associated fibroblasts. Hence, stem cell properties change in time depending on the cell location. Furthermore, although chemotherapy enriches for cells with a CSC phenotype, in this context functional stem cell properties are also fully defined by the microenvironment. To conclude, we identified osteopontin as a key cancer-associated fibroblast-produced factor that drives in situ clonogenicity in colon cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据